Journal of Clinical Epidemiology
Volume 54, Issue 5 , Pages 462-469 , May 2001

The homocysteine distribution: (Mis)judging the burden

  • Angelika de Bree

      Affiliations

    • National Institute of Public Health and the Environment, Department of Chronic Disease Epidemiology, P.O. Box 1, 3720 BA, Bilthoven, The Netherlands
    • Laboratory of Pediatrics and Neurology, University Hospital “St Radboud” Nijmegen, The Netherlands
    • Corresponding Author InformationCorresponding author. Fax: +31 30 274 4407.
    • ,
  • W.M.Monique Verschuren

      Affiliations

    • National Institute of Public Health and the Environment, Department of Chronic Disease Epidemiology, P.O. Box 1, 3720 BA, Bilthoven, The Netherlands
    • ,
  • Henk J Blom

      Affiliations

    • Laboratory of Pediatrics and Neurology, University Hospital “St Radboud” Nijmegen, The Netherlands
    • ,
  • Adriana de Graaf-Hess

      Affiliations

    • Laboratory of Pediatrics and Neurology, University Hospital “St Radboud” Nijmegen, The Netherlands
    • ,
  • Frans J.M Trijbels

      Affiliations

    • Laboratory of Pediatrics and Neurology, University Hospital “St Radboud” Nijmegen, The Netherlands
    • ,
  • Daan Kromhout

      Affiliations

    • National Institute of Public Health and the Environment, Department of Chronic Disease Epidemiology, P.O. Box 1, 3720 BA, Bilthoven, The Netherlands

Received 10 November 1999 ,Revised 3 August 2000 ,Accepted 26 September 2000.

References 

  1. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995;274:1049–1057
  2. Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP, et al. Homocysteine metabolism and risk of myocardial infarction (relation with vitamins B6, B12, and folate). Am J Epidemiol. 1996;143:845–859
  3. den Heijer M, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996;334:759–762
  4. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease (the European concerted action project). JAMA. 1997;277:1775–1781
  5. Kang SS, Wong PW, Norusis M. Homocysteinemia due to folate deficiency. Metabolism. 1987;36:458–462
  6. Giles WH, Croft JB, Greenlund KJ, Ford ES, Kittner SJ. Total homocyst(e)ine concentration and the likelihood of nonfatal stroke (results from the Third National Health and Nutrition Examination Survey, 1988–1994). Stroke. 1998;29:2473–2477
  7. Wald NJ, Watt HC, Law MR, Weir DG, McPartlin J, Scott JM. Homocysteine and ischemic heart disease (results of a prospective study with implications regarding prevention). Arch Int Med. 1998;158:862–867
  8. Bostom AG, Silbershatz H, Rosenberg IH, Selhub J, D'Agostino RB, Wolf PA, et al. Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med. 1999;159:1077–1080
  9. Ubbink JB, Vermaak WJ, van der Merwe A, Becker PJ. The effect of blood sample aging and food consumption on plasma total homocysteine levels. Clin Chim Acta. 1992;207:119–128
  10. Vester B, Rasmussen K. High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Biochem. 1991;29:549–554
  11. Andersson A, Isaksson A, Hultberg B. Homocysteine export from erythrocytes and its implication for plasma sampling. Clin Chem. 1992;38:1311–1315
  12. Moller J, Christensen L, Rasmussen K. An external quality assessment study on the analysis of methylmalonic acid and total homocysteine in plasma. Scand J Clin Lab Invest. 1997;57:613–619
  13. Eliason SC, Ritter D, Chung HD, Creer M. Interlaboratory variability for total homocysteine analysis in plasma. Clin Chem. 1999;45:315–316
  14. Smit HA, Verschuren WMM, Bueno de Mesquita HB, Seidell JC. Monitoring van risicofactoren en gezondheid in Nederland (MORGEN-project): Doelstelling en werkwijze. [The monitoring project on risk factors for chronic diseases in the Netherlands (MORGEN-project): Aim and method]. 1994; report number 263200001:1–93.
  15. Verhoef P, Kok FJ, Kruyssen DA, Schouten EG, Witteman JC, Grobbee DE, et al. Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 1997;17:989–995
  16. Willems HPJ, Bos GMJ, Gerrits WBJ, denHeijer M, Vloet S, Blom HJ. Acidic citrate stabilized blood samples for assay of total homocysteine. Clin Chem. 1998;44:342–345
  17. Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols in plasma and urine (automated determination and sample stability). Clin Chem. 1993;39:263–271
  18. te Poele Pothoff MT, van den Berg M, Franken DG, Boers GH, Jakobs C, de Kroon IF, et al. Three different methods for the determination of total homocysteine in plasma. Ann Clin Biochem. 1995;32:218–220
  19. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum (methods and clinical applications). Clin Chem. 1993;39:1764–1779
  20. Refsum H, Ueland P, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med. 1998;49:31–62
  21. Refsum H, Fiskerstrand T, Guttormsen AB, Ueland PM. Assessment of homocysteine status. J Inherit Metab Dis. 1997;20:286–294
  22. Guttormsen AB, Schneede J, Fiskerstrand T, Ueland PM, Refsum HM. Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects. J Nutr. 1994;124:1934–1941
  23. Brattstrom LE, Israelsson B, Jeppsson JO, Hultberg BL. Folic acid—an innocuous means to reduce plasma homocysteine. Scand J Clin Lab Invest. 1988;48:215–221
  24. Dierkes J. Vitamin requirements for the reduction of homocysteine blood levels in healthy young women. Thesis. Bonn: University of Bonn; 1995;
  25. Cobbaert C, Arentsen JC, Mulder P, Hoogerbrugge N, Lindemans J. Significance of various parameters derived from biological variability of lipoprotein(a), homocysteine, cysteine, and total antioxidant status. Clin Chem. 1997;43:1958–1964
  26. Rossi E, Beilby JP, McQuillan BM, Hung J. Biological variability and reference intervals for total plasma homocysteine. Ann Clin Biochem. 1999;36(Part 1):56–61
  27. Garg UC, Zheng ZJ, Folsom AR, Moyer YS, Tsai MY, McGovern P, et al. Short-term and long-term variability of plasma homocysteine measurement. Clin Chem. 1997;43:141–145
  28. Clarke R, Woodhouse P, Ulvik A, Frost C, Sherliker P, Refsum H, et al. Variability and determinants of total homocysteine concentrations in plasma in an elderly population. Clin Chem. 1998;44:102–107
  29. Nygard O, Refsum H, Ueland PM, Vollset SE. Major lifestyle determinants of plasma total homocysteine distribution (the Hordaland homocysteine study). Am J Clin Nutr. 1998;67:263–270
  30. CBS . Statistich Jaarboek 1996. The Hague: SDU, Statistics; 1996;p. 602. [Statistical yearbook of the Netherlands]
  31. Malinow MR, Axthelm MK, Meredith MJ, MacDonald NA, Upson BM. Synthesis and transsulfuration of homocysteine in blood. J Lab Clin Med. 1994;123:421–429
  32. Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA. 1995;274:1526–1533
  33. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, et al  Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 1997;277:1775–1781
  34. Brattstrom LE, Hultberg BL, Hardebo JE. Folic acid responsive postmenopausal homocysteinemia. Metabolism. 1985;34:1073–1077
  35. Boers GH, Smals AG, Trijbels FJ, Leermakers AI, Kloppenborg PW. Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years. J Clin Invest. 1983;72:1971–1976
  36. Andersson A, Brattstromm L, Israelsson B, Isaksson A, Hamfelt A, Hultberg B. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. Eur J Clin Invest. 1992;22:79–87
  37. Verhoef P, Meleady R, Daly LE, Graham IM, Robinson K, Boers GHJ. Homocysteine, vitamin status and risk of vascular disease—effects of gender and menopausal status. Eur Heart J. 1999;20:1234–1244

PII: S0895-4356(00)00341-3

Journal of Clinical Epidemiology
Volume 54, Issue 5 , Pages 462-469 , May 2001

Article Tools

* Image Usage & Resolution